December 6, 2010 -- China Pharma Holdings has completed its clinical trials of a generic form of a statin-family cholesterol drug, rosuvastatin. Rosuvastatin is marketed by AstraZeneca as Crestor®. China Pharma intends to obtain SFDA approval for the drug and begin selling it next year in China. More details....
